se of platelet eyedrops in diabetic patients with dry eye disease.
- Conditions
- dry eye diseasediabetesC11.496.260
- Registration Number
- RBR-96t463
- Lead Sponsor
- Hemocentro de Alagoas-HEMOA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Diagnose of diabetes following ADA (American Diabetes Association)criteria;moderate or severe dry eye patients with unresponsiveness or a weak response to conventional treatment; having at least a frequent or constant symptom and either a Schirmer test at less than 15mm or a BUT(Break Up Time test) less than 10 seconds.
Individuals under 18; mentally disabled; pregnant women; indigenous people and those who are wards of the state. Patients that had keratopathies; use of glaucoma eyedrops; previous rheumatic disease diagnosis. Patients that had contraindicated conditions to be submitted to autologous donation
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method